1. Home
  2. POLA vs TOVX Comparison

POLA vs TOVX Comparison

Compare POLA & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polar Power Inc.

POLA

Polar Power Inc.

HOLD

Current Price

$1.44

Market Cap

6.0M

Sector

Miscellaneous

ML Signal

HOLD

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.20

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POLA
TOVX
Founded
1979
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
7.2M
IPO Year
2016
2006

Fundamental Metrics

Financial Performance
Metric
POLA
TOVX
Price
$1.44
$0.20
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0M
2.2M
Earning Date
11-19-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$8,326,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$0.17
52 Week High
$5.75
$1.75

Technical Indicators

Market Signals
Indicator
POLA
TOVX
Relative Strength Index (RSI) 39.81 49.60
Support Level $1.45 $0.17
Resistance Level $1.63 $0.20
Average True Range (ATR) 0.28 0.02
MACD -0.02 0.00
Stochastic Oscillator 1.09 70.34

Price Performance

Historical Comparison
POLA
TOVX

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: